Related Experiment Video
Updated: Aug 6, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Supportive care in multiple myeloma
Asher Chanan-Khan1, Kena C Miller
1Roswell Park Cancer Institute, Buffalo, NY 14263, USA. asher.chanan-khan@roswellpark.org
Abstract:
Significant progress in the treatment of multiple myeloma has resulted in improvement of disease control with a trend toward overall and progression-free survival benefit. With the availability of several new therapeutic agents and combinations, a careful emphasis should be placed in the management of disease- and therapy-associated complications. Aggressive management of these complications can impact patients' quality of life as well as treatment outcome. This review highlights some of the critical supportive care measures integral to the optimal care of patients with multiple myeloma.
Related Concept Videos
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease IV: Nursing Management
Treatment Resistant Cancers
Chronic Kidney Disease III: Interprofessional Care
Treatment Resistent Cancers
Myocarditis IV: Nursing Management
